Gerli Sibolt

Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial

Urs Fischer, Johannes Kaesmacher, Daniel Strbian et al. · The Lancet · 2022 · 285 citations · Full text

Medicine, Neurology, Surgery +13

Higher neutrophil counts before thrombolysis for cerebral ischemia predict worse outcomes

Ilaria Maestrini, Daniel Strbian, Sophie Gautier et al. · Neurology · 2015 · 216 citations · Full text

Medicine, Hematology, Neurology +17

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados et al. · The Lancet Neurology · 2018 · 178 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial

Atte Meretoja, Nawaf Yassi, Teddy Y. Wu et al. · The Lancet Neurology · 2020 · 144 citations

Medicine, Pharmacology, Pharmacotherapy +12

Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial

Shelagh B. Coutts, Sandeep Ankolekar, Ramana Appireddy et al. · The Lancet · 2024 · 125 citations · Full text

Medicine, Neurology, Cerebrovascular Surgery +11